| 1 |
35622143 | PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to As2O3 by stabilizing oncoprotein PML-RARα. | 2022 May 27 |
3 |
| 2 |
32854112 | A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia. | 2021 Mar 18 |
1 |
| 3 |
34310740 | RBCK1-TRIB3 decelerated the progression of acute promyelocytic leukemia. | 2021 Oct |
1 |
| 4 |
32163072 | Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases. | 2020 Mar 1 |
1 |
| 5 |
32223133 | Interplay of Ubiquitin-Like Modifiers Following Arsenic Trioxide Treatment. | 2020 May 1 |
5 |
| 6 |
32240679 | Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs. | 2020 Jun 15 |
6 |
| 7 |
32328411 | ATO (Arsenic Trioxide) Effects on Promyelocytic Leukemia Nuclear Bodies Reveals Antiviral Intervention Capacity. | 2020 Apr |
2 |
| 8 |
32435915 | Biotransformation of arsenic and toxicological implication of arsenic metabolites. | 2020 Aug |
2 |
| 9 |
32882258 | Arsenic induced epigenetic changes and relevance to treatment of acute promyelocytic leukemia and beyond. | 2020 Nov 1 |
2 |
| 10 |
33091440 | Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia. | 2020 Dec 15 |
1 |
| 11 |
30763586 | Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells. | 2019 Mar 15 |
2 |
| 12 |
30824184 | Identification of a point mutation PMLS214L-RARα that alters PML body organization, dynamics and SUMOylation. | 2019 Apr 9 |
4 |
| 13 |
31214877 | Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin-proteasome pathway. | 2019 Aug |
1 |
| 14 |
31670356 | Irreversibility of arsenic trioxide induced PML/RARα fusion protein solubility changes. | 2019 Dec 11 |
3 |
| 15 |
28521962 | The functional roles of PML nuclear bodies in genome maintenance. | 2018 May |
1 |
| 16 |
29387217 | Effects of lapatinib on cell proliferation and apoptosis in NB4 cells. | 2018 Jan |
2 |
| 17 |
29596829 | Influence of acute promyelocytic leukemia therapeutic drugs on nuclear pore complex density and integrity. | 2018 May 15 |
2 |
| 18 |
29973452 | [Acute promyelocytic leukemia: state-of-the-art management]. | 2018 |
2 |
| 19 |
30026570 | Molecular remission as a therapeutic objective in acute promyelocytic leukemia. | 2018 Aug |
2 |
| 20 |
30259936 | Arsenic trioxide preferentially binds to the ring finger protein PML: understanding target selection of the drug. | 2018 Nov 14 |
3 |
| 21 |
30662778 | An Unusual Coexistence of Primary Central Nervous System Non-Hodgkin's Lymphoma and Acute Promyelocytic Leukemia. | 2018 |
1 |
| 22 |
30693698 | [Involvement of PML proteins in treatment of acute promyelocytic leukemia with arsenic trioxide]. | 2018 May 25 |
13 |
| 23 |
27903803 | The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation. | 2017 Feb 15 |
1 |
| 24 |
28028657 | PML-RARA mutations confer varying arsenic trioxide resistance. | 2017 Apr |
1 |
| 25 |
28125064 | Phenylarsine Oxide Can Induce the Arsenite-Resistance Mutant PML Protein Solubility Changes. | 2017 Jan 25 |
2 |
| 26 |
28129653 | RXRα ligand Z-10 induces PML-RARα cleavage and APL cell apoptosis through disrupting PML-RARα/RXRα complex in a cAMP-independent manner. | 2017 Feb 14 |
1 |
| 27 |
28239645 | PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes. | 2017 Feb 23 |
3 |
| 28 |
28486108 | TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence. | 2017 May 8 |
2 |
| 29 |
28492552 | All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells. | 2017 May 11 |
4 |
| 30 |
28525371 | Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylation. | 2017 Jul 11 |
5 |
| 31 |
28656178 | Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines. | 2017 May-Jun |
1 |
| 32 |
28695742 | Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation. | 2017 Sep 1 |
2 |
| 33 |
28712407 | [Detection and clinical significance of PML protein expression of acute promyelocytic leukemia cells]. | 2017 Jul |
2 |
| 34 |
26537301 | Varying responses of PML-RARA with different genetic mutations to arsenic trioxide. | 2016 Jan 14 |
2 |
| 35 |
26728337 | Mutations affecting both the rearranged and the unrearranged PML alleles in refractory acute promyelocytic leukaemia. | 2016 Mar |
3 |
| 36 |
27030546 | PCGF2 negatively regulates arsenic trioxide-induced PML-RARA protein degradation via UBE2I inhibition in NB4 cells. | 2016 Jul |
7 |
| 37 |
27133819 | PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy. | 2016 Oct |
1 |
| 38 |
25759405 | A novel clonal t(1;4)(p36.1;q31) translocation in acute promyelocytic leukaemia. | 2015 May |
1 |
| 39 |
25795919 | Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells. | 2015 May 28 |
3 |
| 40 |
26058416 | Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancer. | 2015 Dec |
2 |
| 41 |
26060329 | SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML. | 2015 Jun 9 |
2 |
| 42 |
26118777 | Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma. | 2015 Sep 28 |
9 |
| 43 |
26213848 | Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation. | 2015 Sep 22 |
4 |
| 44 |
26294332 | Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients. | 2015 Nov |
2 |
| 45 |
26517826 | Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts. | 2015 |
2 |
| 46 |
27182481 | Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia. | 2015 |
2 |
| 47 |
24907012 | Understanding the molecular pathogenesis of acute promyelocytic leukemia. | 2014 Mar |
4 |
| 48 |
25319615 | Molecular mechanisms of the antileukemia activities of retinoid and arsenic. | 2014 |
4 |
| 49 |
23208507 | The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability. | 2013 Oct 24 |
1 |
| 50 |
23430110 | Selective inhibition of the NLRP3 inflammasome by targeting to promyelocytic leukemia protein in mouse and human. | 2013 Apr 18 |
2 |